Cite
HARVARD Citation
Nakamura, A. et al. (2020). Phase II Study of Low‐Dose Afatinib Maintenance Treatment Among Patients with EGFR‐Mutated Non‐Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1601 (NJLCG1601). Oncologist. pp. e1451-e1456. [Online].